90
Views
8
CrossRef citations to date
0
Altmetric
Article

Combination therapy consisting of week pulses of oral terbinafine plus topical application of terbinafine cream in the treatment of onychomycosis

, , &
Pages 245-251 | Received 26 Jan 2004, Accepted 22 Apr 2004, Published online: 12 Jul 2009

References

  • Kejda J, Itraconazole pulse therapy vs continuous terbinafine dosing for toenail onychomycosis. Postgrad Med 1999; Spec No: 12–15.
  • Harrell TK, Necomb WW, Replogle WH et al, Onycho- mycosis: improved cure rates with itraconazole and terbinafine. J Am Board Fam Pract (2000) 13: 268–73.
  • Hiruma M, Matsushita A, Kobayashi M et al, One week pulse therapy with itraconazole (200 mg day-1) for onychomycosis. Evaluation of treatment results accord- ing to patient background. Mycoses (2001) 44: 87–93.
  • Gupta AK, Lynde CW, Konnikov N, Single-blind, randomized, prospective study of sequential itraconazole and terbinafine pulse compared with terbinafine pulse for the treatment of toenail onychomycosis. J Am Acad Dermatol (2001) 44: 485–91.
  • Jain S, Sehgal VN, Itraconazole versus terbinafine in the management of onychomycosis: an overview. J Dermatol Treat (2003) 14: 30–42.
  • Faergemann J, Zehender H, Denouel J et al, Levels of terbinafine in plasma, stratum corneum, dermis- epidermis (without stratum corneum), sebum, hair and nails during and after 250 mg terbinafine orally once per day for four weeks. Acta Derm Venereol (1993) 73: 305–9.
  • Debruyne D, Coquerel A, Pharmacokinetics of antifungal agents in onychomycoses. Clin Pharmacokinet (2001) 40: 441–72.
  • Heikkila H, Stubb S, Long-term results in patients with onychomycosis treated with terbinafine or itraconazole. Br J Dermatol (2002) 146: 250–3.
  • Tosti A, Piraccini BM, Stinchi C et al, Treatment of dermatophyte nail infections: an open randomized study comparing intermittent terbinafine therapy with con- tinuous terbinafine treatment and intermittent itraco- nazole therapy. J Am Acad Dermatol (1996) 34: 595–600.
  • Alpsoy E, Yilmaz E, Basaran E, Intermittent therapy with terbinafine for dermatophyte toe-onychomycosis: a new approach. J Dermatol (1996) 23: 259–62.
  • Warshaw EM, Carver SM, Zielke GR et al, Intermittent terbinafine for toenail onychomycosis: is it effective? Results of a randomized pilot trial. Arch Dermatol (2001) 137: 1253.
  • Darkes MJ, Scott LJ, Goa KL, Terbinafine: a review of its use in onychomycosis in adults. Am J Clin Dermatol (2003) 4: 39–65.
  • Scher RK, Onychomycosis: therapeutic update. J Am Acad Dermatol (1999) 40: S21–6.
  • Gupta AK, Adam P, Terbinafine pulse therapy is effective in tinea capitis. Pediatr Dermatol (1998) 15: 56–8.
  • Albanese G, Di Cintio R, Martini C, Nicoletti A, Short therapy for tinea unguium with terbinafine: four differ- ent courses of treatment. Mycoses (1995) 38: 211–14.
  • Gupta AK, Ryder J, Summerbell RC, Comparison of efficacy criteria across onychomycosis trials: need for standardization. Int J Dermatol (2003) 42: 312–15.
  • Evans EG, Drug synergies and the potential for combination therapy in onychomycosis. Br J Dermatol (2003) 149 (suppl 65): 11–13.
  • Olafsson JH, Sigurgeirsson B, Baran R, Combination therapy for onychomycosis. Br J Dermatol (2003) 149 (suppl 65): 15–18.
  • Rigopoulos D, Katoulis AC, Ioannides D et al, A randomized trial of amorolfine 5% solution nail lacquer in association with itraconazole pulse therapy compared with itraconazole alone in the treatment of Candida fingernail onychomycosis. Br J Dermatol (2003) 149: 151–6.
  • Evans EG, The rationale for combination therapy. Br J Dermatol (2001) 145 (suppl 60): 9–13.
  • Baran R, Topical amorolfine for 15 months combined with 12 weeks of oral terbinafine, a cost-effective treatment for onychomycosis. Br J Dermatol (2001) 145 (suppl 60): 15–19.
  • Lecha M, Amorolfine and itraconazole combination for severe toenail onychomycosis; results of an open randomized trial in Spain. Br J Dermatol (2001) 145 (suppl 60): 21–6.
  • Baran R, Feuilhade M, Combernale P et al, A randomized trial of amorolfine 5% solution nail lacquer combined with oral terbinafine compared with terbina- fine alone in the treatment of dermatophytic toenail onychomycoses affecting the matrix region. Br J Dermatol (2000) 142: 1177–83.
  • Reinel D, Clarke C, Comparative efficacy and safety of amorolfine nail lacquer 5% in onychomycosis, once- weekly versus twice-weekly. Clin Exp Dermatol (1992) 17 (suppl 1): 44–9.
  • Gupta AK, Ryder JE, Baran R, The use of topical therapies to treat onychomycosis. Dermatol Clin (2003) 21: 481–9.
  • Faergemann J, Baran R, Epidemiology, clinical presenta- tion and diagnosis of onychomycosis. Br J Dermatol (2003) 149 (suppl 65): 1–4.
  • Scher RK, Baran R, Onychomycosis in clinical practice: factors contributing to recurrence. Br J Dermatol (2003) 149 (suppl 65): 5–9.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.